How can orthopedic biomaterials reduce the "Total Cost of Care"?

Hospital executives in the Americas are no longer just looking at the purchase price of an implant; they are looking at the longitudinal cost of the patient journey. A biomaterial that is $500 more expensive but reduces the length of hospital stay by one day or lowers the 90-day readmission rate is effectively a cost-saving measure.

How is Orthopedic Bone Cement market share shifting in 2024?

In the highly competitive U.S. market, Orthopedic Bone Cement is becoming a strategic tool for risk management. High-viscosity cements that allow for faster surgical closure and antimicrobial-loaded variants are gaining market share among procurement teams focused on bundled payment models. For strategy heads, analyzing these shifts is key to maintaining a competitive edge in the Americas.

Does the 'Standardization' of biomaterials threaten innovation?

While health systems are pushing for SKU (Stock Keeping Unit) rationalization to save costs, they must balance this with the need for high-performance materials. The trend for 2025 is toward "Evidence-Based Standardization," where surgeons and procurement teams collaborate to select a core set of biomaterials that are proven to deliver the best clinical outcomes across the largest patient population.

  • Shift toward "risk-sharing" agreements between manufacturers and hospitals.
  • Utilization of real-world evidence (RWE) to justify premium material costs.
  • Emphasis on materials that support "Same-Day" joint replacement programs.

2025 Procurement Trend: Sustainability

By 2025, environmental impact will enter the procurement equation. We expect to see a growing demand for biomaterials with reduced packaging waste and manufacturers with carbon-neutral production processes.

Author: Sofiya Sanjay

Designation: Healthcare Research Consultant, Market Research Future

About: At Market Research Future (MRFR), we enable organizations to unravel complex industries through Cooked Research Reports (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services. Our studies across products, technologies, applications, end users, and global to country-level segments help decision-makers see more, know more, and do more.

Contact: 99 Hudson Street, 5th Floor, New York, NY 10013, USA | (855) 661-4441 (US) | +44 1720 412 167 (UK) | +91 2269738890 (APAC) | info@marketresearchfuture.com